Histologic chorioamnionitis: An occult marker of severe pulmonary hypertension in the term newborn

Journal of Perinatology

Volumn 25, Issue 3, 2005, Pages 189-192

  Woldesenbet, Mesfin ^a   Perlman, Jeffrey M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; NITRIC OXIDE; OXYGEN;

ARTICLE; ASSISTED VENTILATION; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; GESTATIONAL AGE; HIGH FREQUENCY OSCILLATION; HIGH FREQUENCY VENTILATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD; NEWBORN; NEWBORN DEATH; NEWBORN DISEASE; OUTCOMES RESEARCH; PLACENTA DISORDER; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

CHORIOAMNIONITIS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT, NEWBORN; MALE; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; PREGNANCY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 16244368499     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211240     Document Type: Article

References (23)

1. Frederick CM, Stenmark KR. Persistent pulmonary hypertension of the newborn. Am J Resp Crit Care Med 1995;151:2010-32.
2. Kinsella JP, Abman SH. Efficacy of inhalational nitric oxide therapy in the clinical management of persistent pulmonary hypertension of the newborn. Chest 1994;105(3):92S-4S.
3. Heyman J, Adams A, Gardner T. PPHN: trends, incidence, diagnosis, and management. Am J Dis Child 1984;138:592-5.
4. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the newborn. Pediatrics 1998;101(3):325-34.
5. The Neonatal Inhaled Nitric Oxide Group. Inhaled nitric oxide in full term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
6. Roberts JD, Morin III FC, Shaul PW, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. New Engl J Med 1997;336:605-10.
7. Abman SH. Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Neoreviews 1999;20(11):e103-9.
8. Zhang J, Patel JM, Li YD, et al. Proinflammatory cytokines downregulate gene expression and activity of eNOS in porcine pulmonary artery endothelial cells. Res Comm Molec Pathol Pharm 1997;96:71-87.
9. Venugopal SK, Devaraj S, Shaul P, et al. Demonstration that CRP decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.
10. Verma S, Wang CH, Stewart DJ, et al. A self-fulfilling prophecy. CRP attenuates NO production and inhibits angiogenesis. Circulation 2002;106:913-9.
11. Ziesche R, Petkov V, Williams J, et al. Lipopolysaccharide and interleukin 1 augement the effects of hypoxia and inflammation in human pulmonary arterial tissue. Proc Natl Acad Sci USA 1996;93:12478-83.
12. Asrat T. Intra-amniotic infection in patients with preterm prelabor rupture of membranes. Pathophysiology, detection and management. Clin Perinatol 2001;28(4):735-51.
13. Shalak LF, Laptook AR, Perlman JM, et al. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 2002;110(4):673-80.
14. Ballard JL, Khoury JC, Wedig K, et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991;119:417-23.
15. Alexander JM, McIntire DM, Levino KJ. Chorioamnionitis and the prognosis for term infants. Obstet & Gynecol 1999;94:274-8.
16. Romero R, Salafia C, Athanissiadis AP, et al. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol 1992;166:1382-8.
17. Gilstrap LC, Levino KJ, Burris J, et al. Diagnosis of birth asphyxia on the basis of fetal pH, Apgar score and newborn cerebral dysfunction. Am J Obstet Gynecol 1989;161:825-30.
18. Winkler CL, Hauth JC, Tucker JM, et al. Neonatal complications at term related to the degree of umbilical artery acidemia. Am J Obstet Gynecol 1991;164:637-41.
19. Cornfield DN, Chatfield BA, Abman SH, et al. Effect of birth related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol 1992;31:H1474-81.
20. Shaul PW, Farrar MA, Zeller TM. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am J Physiol 1992;262:H355-64.
21. Morin III FC, Eagan EA, Ferguson W, et al. Development of pulmonary vascular response to oxygen. Am J Physiol 1998;254:H542-6.
22. Konduri GG, Mattei J. Role of oxidative phosphorylation and ATP release in mediating birth-related pulmonary vasodilation in fetal lambs. Am J Physiol 2002;283(4):H1600-8.
23. McQuillan LP, Gordon KL, Marsden PA, et al. Hypoxia inhibit expression of eNOS via transcriptional and post-transcriptional mechanisms. Am J Physiol 1994;267:H1921-7.